Parmax Pharma Ltd — Important, 12-01-2026: Company Update

Parmax Pharma Limited has confirmed its adherence to share dematerialization rules for the quarter ended December 31, 2025. The company ensures that physical shares received for dematerialization are promptly verified, mutilated, and cancelled, with the depositories duly registered as the new owners in its records. This systematic process ensures the integrity of the company's share registry. All dematerialized securities are confirmed to be listed on the stock exchanges, providing transparency and facilitating smooth trading for shareholders. This demonstrates efficient management of investor records and regulatory compliance.